About Continuity Biosciences
Continuity Biosciences is a private company based in Bradenton, Florida, incorporated in 2023 in Delaware. It has reported $11,874,490 raised in three offerings on Form D since July 2024. Its chief executive is Ramakrishna Venugopalan.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Aug 12, 2025 | Aug 19, 2025 | $8,424,490of $12.0M target | 13 | $648K | EquityRule 506(b) | Form D ↗ |
| May 28, 2025 | Jun 4, 2025 | $1,000,000fully sold | 13 | $76,923 | EquityRule 506(b) | Form D ↗ |
| Jun 20, 2024 | Jul 2, 2024 | $2,450,000of $5.0M target | 10 | $245K | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $11,874,490 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Continuity Biosciences's Form D filed Aug 19, 2025.
MF
Michael Fowler
Director
AW
Allen Weiss
Director
MR
Monica Reed
Director
JD
Joseph DeSimone
Director
RV
Ramakrishna Venugopalan
Chief Executive Officer and director
RW
Robert Whitehead
Director
JT
Josephine Torrente
Director